Identification of metastasis-associated genes in early stage non-small cell lung cancer by subtractive hybridization

Acta Biochimica et Biophysica Sinica

Volumn 34, Issue 3, 2002, Pages 273-278

  Wang, Wen Bing ^a,b   Böing, Sebastian ^a   Zhou, Xiao Qin ^a   Ji, Ping ^a   Dong, Yin ^b   Yao, Qin ^b   Müller Tidow, Carsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Expression; Gene; Metastasis; Non small cell lung cancer; Subtractive hybridization

Indexed keywords

RNA;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA LIBRARY; EARLY CANCER; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; EUKARYOTIC INITIATION FACTOR-4A; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PEPTIDE INITIATION FACTORS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0036395153     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pepper MS. Lymphangiogenesis and tumor metastasis: Myth or reality? Clin Cancer Res, 2001, 7: 462-468
2. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res, 2001, 7: 14-23
3. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 1992, 340: 145-146
4. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res, 2000, 60: 203-212
5. Hesketh R. The Oncogene and Tumour Suppressor Gene Facts Book, 2nd ed, London: Harcourt Brace & Company, 1997, 3-69
6. Kraus-Berthier L, Jan M, Guilbaud N, Naze M, Pierre A, Atassi G. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice. Clin Cancer Res, 2000, 6:297-304
7. Johnson JR, Hammond WG, Benfield JR, Tesluk H. Successful xenotransplantation of human lung cancer correlates with the metastatic phenotype. Ann Thorac Surg, 1995, 60: 32-36
8. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410: 50-56
9. Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC et al. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res, 1998, 58: 5690-5694
10. Sleeman JP. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results. Cancer Res, 2000, 157: 55-81
11. Weston WM, LeClair EE, Trzyna W, McHugh KM, Nugent P, Lafferty CM, Ma L et al. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J Biol Chem, 1999, 274: 13698-13703
12. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med, 2000, 343: 1217-1222
13. Parkin DM. Trends in lung cancer incidence worldwide. Chest, 1996, 96: 5-8
14. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin, 1997, 47: 5-27
15. Müller-Tidow C, Metzger R, Kugler K, Diederichs S, Idos G, Thomas M, Dockhorn-Dworniczak B et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung Cancer. Cancer Res, 2001, 61: 647-653
16. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res, 1996, 6: 995-1001
17. Heid CA, Stevens J, Livak KJ, and Williams PM. Realtime quantitative PCR. Genome Research, 1996, 6: 986-994.
18. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl, 1995, 4: 357-362
19. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 2000, 406: 536-540
20. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res, 1995, 55: 3988-3991
21. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro E JR et al. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes Cancer, 1998, 22: 130-137
22. Gortz B, Roth J, Krahenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol, 1999, 154: 429-436
23. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem, 1999, 68: 913-963
24. Rosell R, Font A, Pifarre A, Canela M, Maurel J, Arellano A, Izquierdo J. The role of induction (neoadjuvant) chemotherapy in stage IIIA NSCLC. Chest, 1996, 109: 102-106